Article PDF
References
Krans HMJ, Porta M, Keen H . Diabetes care and research in Europe: the St Vincent Declaration action programme. Geneva: WHO, 1992.
The Report: St Vincent Joint Task Force for Diabetes. London: Department of Health and the British Diabetic Association, 1995.
The British Multicentre Study Group. Photocoagulation in diabetic maculopathy. Lancet 1976;75:110–3.
The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976;81:383–96.
Ghafour IS, Allan D, Foulds WS . Common causes of blindness and visual handicap in the West of Scotland. Br J Ophthalmol 1983;67:209.
Grey RHB, Burns-Cox CJ, Hughes A . Blind and partial sight registration in Avon. Br J Ophthalmol 1989;73:88.
Bruce IWI, McKennall AC, Walker EC . Blind and partial sighted adults in Britain. RNIB Survey 1991, vol. 1. London: HMSO, 1991.
Patel V, Rassam SMB, Kohner EM . Screening for diabetic retinopathy in general practice: feasibility and limitations. Diabetic Med 1992;9:117a.
Buxton MJ. Sculpher MJ, Ferguson BA, et al. Screening for treatable diabetic retinopathy. Diabetic Med 1991;8:371.
Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: ETDRS report I. Arch Ophthalmol 1985;103:1796.
British Multicentre Study Group. Photocoagulation for diabetic maculopathy. Diabetes 1983;32:1010.
DCCT. The effect of intensive treatment on development and progression of long term complications in insulin dependent diabetes. N Engl J Med 1993;329:997.
UK Prospective Study of Therapies of Maturity-onset Diabetes. Reduction of HbA1c with basal insulin supplement, sulfonylurea or biguanide therapy: multi-centre study. Diabetes 1985;34:793–8.
Rights and permissions
About this article
Cite this article
Cheng, H. The St Vincent declaration: A new charter?. Eye 10, 411–412 (1996). https://doi.org/10.1038/eye.1996.91
Issue Date:
DOI: https://doi.org/10.1038/eye.1996.91